We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Kidney Injury

News List

First Patient Dosed in DUR-928 Study in COVID-19 Patients with Acute Liver, Kidney Injury americanpharmaceuticalreview
September 30, 2020
DURECT has dosed the first patient in its randomized, double-blind, placebo-controlled, multi-center Phase 2 study to evaluate the safety and efficacy of DUR-928 in hospitalized COVID-19 patients with acute liver or kidney injury.
SeaStar to Study Selective Cytopheretic Device in COVID-19 Patients with ARDS, Kidney Injury americanpharmaceuticalreview
May 04, 2020
SeaStar Medical has received approval of their Investigational Device Exemption (IDE) supplement from the U.S. Food and Drug Administration (FDA) to initiate a feasibility, compassionate use study.